Anggot, Gregorio .

HRN: 01-24-46  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/15/2025
07/06/2025
IV
350mg
Q24h
CAP
Pending Pharmacy Acceptance 

 Indication:  Culture-directed    Type of Infection:  Pneumonia    Compliance to guidelines: